Purchase any WEBINAR and get
10% Off
Validity : 23rd Mar'24 to 02nd Apr'24
Laboratories need to transition technologies all of the time. From new ways to perform assays, to outdated technology, to new equipment pushes to the various needs of end users, assays need to switch between technologies on a regular basis. One needs to be able to easily and robustly transition assays from one technology to another. With this seminar, you will be able to fully understand how your assay is currently running and make note of what the new technology should be able to do. Then you will learn how to slowly get the new technology up and running, validating the quality system, equipment and the assay itself. You will learn what you need to understand in the process of transitioning old samples onto the new system and deal with any potential issues.
Finally, you will develop a final validation plan that will allow you to embrace the new technology fearlessly. Assays performed by hand have a number of issues that may be assuaged by automation. One problem can be a simple lack of throughput, as a single worker, no matter how skilled, can only do so much work in a day. As technology progresses, there may be a need to automate a procedure so that a given laboratory may remain state-of-the-art. Finally, the automation of procedures may unlock key new capabilities that may enhance productivity in ways that may not be feasible using manual methods. That said, automating laboratory assays from manual methods is rarely as simple as bringing in equipment, programming the assay in and letting it run. A certain level of know-how is needed in order to understand the various pitfalls and issues that come with automating an assay.
Todd Graham, is a masters-level bench scientist and medical technologist with a host of experience in both the clinical diagnostics and biotechnology fields. Mr. Graham has work for a number of start-up firms in the clinical diagnostics and biotechnology industries, as well as worked for larger firms within both industries. He has a broad level of expertise in assay development for quality control, pharmaceutical development and clinical diagnostics. His particular levels of expertise are molecular diagnostics, PCR, ELISA, quality control and training of bench level personnel in clinical diagnostics and biotechnology. He is also in the process of establishing a consultancy that assists academic labs in transitioning their research to industry by verifying and improving the quality of their work.